109221 ⎘
Applications; Uses Special therapeutic applications
Compositions for modulating C9ORF72 expression
#602RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#603MicroRNAs for cardiac regeneration through induction of cardiac myocyte proliferation
#604EGFR gene expression-suppressing siRNA, precursor of same, and applications thereof
#605Drug delivery using aptamer construct
#606Lipid formulations for delivery of therapeutic agents
#607Selectively altering microbiota for immune modulation
#608Oligonucleotide compounds for targeting huntingtin mRNA
#609MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#610COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
#611Pharmaceutical composition for treating and/or preventing cancer
#612TMPRSS6 iRNA compositions and methods of use thereof
#613Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#614RNA PRODUCTS AND USES THEREOF
#615COMPOSITIONS AND METHODS RELATING TO C5L2
#616Modulation of GYS1 expression
#617MicroRNA-198 as a tumor suppressor in ovarian cancer
#618ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#619INHIBITION OF HISTONE METHYLTRANSFERASE FOR CARDIAC REPROGRAMMING
#620Manipulated immunoregulatory element and immunity altered thereby
#621MARKER FOR THE CLASSIFICATION, DIAGNOSIS AND TREATMENT OF SCOLIOSIS
#622Exon skipping compositions for treating muscular dystrophy
#623Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#624Genomic sequences encoding for an attenuated mutant Zika virus
#625MODULATION OF TRANSTHYRETIN EXPRESSION
#626Methods of Manipulating the Fate of Cells
#627Methods of treating conditions involving elevated inflammatory response
#628Compositions and methods for treating cancer
#629Targeting MicroRNAs for Metabolic Disorders
#630RNA containing composition for treatment of tumor diseases
#631RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#632MicroRNA Compounds and Methods for Modulating MIR-122
#633Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#634Methods involving Menain screening for inhibitors of cancer invasion and metastasis
#635Method for preventing or treating obesity by using a composition including HOGA1-inhibiting substance and method of screening a preventive or therapeutic agent for obesity by using the composition
#636Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation
#637MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD
#638SINGLE-STRANDED RNAI OLIGONUCLEOTIDES TARGETING APOC-III
#639Lentiviral vector capable of directly reflecting type I interferon response, preparation method thereof, and applications thereof
#640Compositions and methods for inhibiting expression of TMPRSS6 gene
#641miRNA for treatment of breast cancer
#642METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#643Glycosylated oligonucleotides that mimic the HIV-1 epitope of neutralizing monoclonal antibody 2G12
#644Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure
#645CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF
#646siRNA And Their Use In Methods And Compositions For Inhibiting The Expression Of The ORAI1 Gene
#647Chiral design
#648Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies
#649Conserved HBV and HCV sequences useful for gene silencing
#650METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER
#651Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#652In-vitro induction of adult stem cell expansion and derivation
#653Methods of modulating KEAP1
#654RNA construct and methods of use thereof for enhancing the therapeutic effects of cytotoxic cells and stem cells
#655Nanoparticle to target cancer
#656ANTI-TUMOR THERAPY
#657Methods for treating hypercholesterolemia
#658RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#659COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF CANCER USING SLNCR ISOFORMS
#660Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
#661Modulation of angiopoietin-like 3 expression
#662Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#663Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#664Cell Differentiation Marker and its Uses
#665Micro-RNAS and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditions
#666RNA containing composition for treatment of tumor diseases
#667Compositions and methods for inhibiting expression of CD274/PD-L1 gene
#668Oligomers
#669Pharmaceutical composition for treating and/or preventing cancer
#670HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL
#671Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof
#672BIOLOGICAL MATERIALS AND USES THEREOF
#673RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions
#674METHODS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES OR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF
#675Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
#676Methods and compositions for inhibiting detoxification response
#677Oligonucleotide compositions with enhanced efficiency
#678COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE
#679PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS
#680Materials and methods for treatment of alpha-1 antitrypsin deficiency
#681Method for diagnosing and treating ovarian cancer
#682Methods and compositions for the specific inhibition of β-catenin by double-stranded RNA
#683Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#684Identification and use of new tumor-promoting gene in hematological malignancies
#685Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#686THERAPEUTIC AND DIAGNOSTIC MOLECULES
#687ANTISENSE MOLECULES FOR TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTION
#688Mobilizing leukemia cells
#689MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER
#690POLYNUCLEOTIDES FOR MULTIVALENT RNA INTERFERENCE, COMPOSITIONS AND METHODS OF USE THEREOF
#691Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#692TREATMENT OF INFLAMMATORY DISEASES
#693Compositions and their uses directed to huntingtin
#694Oncolytic viral vectors and uses thereof
#695THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#696Antisense composition and method for treating muscle atrophy
#697Antisense Polynucleotides to Induce Exon Skipping and Method of Treating Dystrophies
#698MODULATION OF AXON DEGENERATION
#699Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
#700Methods and compositions related to T-cell activity
#701STAT3 inhibitors and uses thereof
#702Pharmaceutical composition for preventing and treating metabolic disease comprising MKRN1 expression or activity inhibitor as an active ingredient
#703METHODS AND COMPOSITIONS FOR PREVENTING ISCHEMIA REPERFUSION INJURY IN ORGANS
#704DNA aptamer that binds to vWF
#705MicroRNA Compounds and Methods for Modulating MIR-21 Activity
#706Targeting MicroRNAs for the Treatment of Fibrosis
#707Chemically ligated RNAs for CRISPR/Cas9-1gRNA complexes as antiviral therapeutic agents
#708METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#709KIR3DL2 IS A BIOMARKER AND A THERAPEUTIC TARGET USEFUL FOR RESPECTIVELY PREVENTING AND TREATING A SUBSET OF CUTANEOUS AND NON-CUTANEOUS PERIPHERAL T-CELL LYMPHOMAS
#710Aptamers for the treatment of sickle cell disease
#711Bioactive renal cells
#712MODULATION OF TRANSTHYRETIN EXPRESSION
#713Compositions and their uses directed to huntingtin
#714Treating and preventing microbial infections
#715Viral vectors for the treatment of diabetes
#716RNA preparations comprising purified modified RNA for reprogramming cells
#717Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
#718BIOMARKERS ASSOCIATED WITH BRM INHIBITION
#719Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds
#720Targeting microRNAs for metabolic disorders
#721Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#722ANTISENSE DESIGN
#723ANTISENSE DESIGN
#724METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#725METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#726METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#727METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#728Methods and compositions for RNA-guided treatment of HIV infection
#729METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#730Methods of identifying and treating poor-prognosis cancers
#731Method of treating pain with an antibody against netrin-4, UNC5B or neogenin
#732METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#733METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#734METHODS AND COMPOSITIONS FOR RNRA-GUIDED TREATMENT OF HIV INFECTION
#735METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#736COMPOSITIONS AND METHODS FOR THE MODULATION OF DNA DAMAGE RESPONSES USING BAL1 AND BBAP
#737METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#738HSD17B13 variants and uses thereof
#739Sustained polypeptide expression from synthetic, modified RNAs and uses thereof
#740METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#741Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#742RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES
#743METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#744Compositions, systems and methods for cell therapy
#745Fidgetin-like 2 as a target to enhance wound healing
#746Albumin production and cell proliferation
#747Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)
#748COMPOUNDS AND METHODS FOR MODULATING TARGET NUCLEAR AND SUB-NUCLEAR NUCLEIC ACID MOLECULES IN CELLS AND ANIMALS
#749METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#750Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#751Modified L-Nucleic Acid
#752COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#753Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#754Antisense oligonucleotides for treatment of cancer stem cells
#755Targeting microRNAs for metabolic disorders
#756siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#757METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#758Methods and compositions for RNA-guided treatment of HIV infection
#759METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#760SDF-1 Binding Nucleic Acids
#761In vivo production of small interfering RNAs that mediate gene silencing
#762Micro-RNA family that modulates extracellular matrix genes and uses thereof
#763Materials and methods for modulation of tendon healing
#764INHIBITION OF EXPANSION AND FUNCTION OF PATHOGENIC AGE-ASSOCIATED B CELLS AND USE FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASE
#765Methods and compositions for treatment of a genetic condition
#766Chemical modification of short small hairpin RNAs for inhibition of gene expression
#767MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION
#768Delivery of therapeutic agent
#769Use of aptamers in therapy and/or diagnosis of autoimmune diseases
#770Compositions and methods for inhibiting expression of factor V
#771Methods and compositions for treatment of a genetic condition
#772Antisense compounds targeting genes associated with cystic fibrosis
#773GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS
#774RNA interference-based therapeutic against anthrax
#775Smooth muscle specific inhibition for anti-restenotic therapy
#776Targeted RNA knockdown and knockout by type III-A Csm complexes
#777Compositions for treating muscular dystrophy
#778METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#779Novel linker, preparation method, and application thereof
#780Organic compositions to treat EPAS1-related diseases
#781Exosomes and micro-ribonucleic acids for tissue regeneration
#782Compositions and methods for the treatment of nucleotide repeat expansion disorders
#783COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#784Method for diagnosing and treating ovarian cancer
#785Oligonucleotide compounds for targeting huntingtin mRNA
#786Methods to detect motor neuron disease comprising micro-RNAs
#787BACTERIAL MEDIATED THF ALPHA GENE SILENCING
#788TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#789Oligonucleotide compositions with enhanced efficiency
#790Method of treating diabetic nephropathy in a subject suffering from type 2 diabetes by administering an antibody which inhibits VEGF-B signaling
#791Micro-RNA inhibitors and their uses in disease
#792NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORS
#793RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#794RNA products and uses thereof
#795NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#796Biodegradable lipids for the delivery of active agents
#797Methods for the diagnosis and treatment of Sjögren's syndrome
#798Nutlin-3a for Treatment of Proliferative Vitreoretinopathy
#799MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS
#800ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
#801Preeclampsia
#802METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#803DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TO P53 AND METHODS OF USE THEREOF
#804ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TREATING DYSTROPHIES
#805Compositions and methods for inhibiting expression of the ALAS1 gene
#806Therapeutic miRNAs for treating heart and skeletal muscle diseases
#807Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation
#808Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#809Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#810Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers
#811Compositions and methods for inhibiting gene expression of factor XII
#812Biological Materials and Uses Thereof
#813Compositions and methods for regulating arterial tone
#814Methods and agents to increase therapeutic dystrophin expression in muscle
#815EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#816Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells
#817Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
#818Compositions and methods to promote erythropoiesis
#819Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#820Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof
#821Composition for reducing cellular senescence level including activity inhibitor inhibiting DCUN1D3 activity or expression inhibitor inhibiting expression of DCUN1D3-encoding gene and use thereof
#822Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#823Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer
#824Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds
#825ADAM12 inhibitors and their use against inflammation-induced fibrosis
#826MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION
#827RNA targeting in alpha-synucleinopathies
#828Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
#829Reduction of off-target RNA interference toxicity
#830EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#831Factor V/Va-targeting aptamer compositions and methods of using the same
#832TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN
#833Compositions for modulating C9ORF72 expression
#834Methods of using microRNA-199A
#835METHODS FOR TREATING HYPERCHOLESTEROLEMIA
#836USE OF MICRORNA PRECURSORS AS DRUGS FOR INDUCING CD34-POSITIVE ADULT STEM CELL EXPANSION
#837Antisense design
#838Antisense design
#839Structurally designed shRNAs
#840ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF
#841Methods and compositions for preventing ischemia reperfusion injury in organs
#842Inhibitory oligonucleotide and use thereof
#843Methods for treating and/or limiting development of diabetes
#844Purification and purity assessment of RNA molecules synthesized with modified nucleosides
#845Selective Reactivation of Genes on the Inactive X Chromosome
#846OLIGONUCLEOTIDES FOR GENOMIC DNA EDITING
#847Oligonucleotide compositions with enhanced efficiency
#848Compositions and methods for inhibiting expression of transthyretin
#849Method for producing lipoplex for topical administration and antitumor agent using such lipoplex
#850Antisense-oligonucleotides as inhibitors of TGF-R signaling
#851METHODS FOR TREATING EYE DISORDERS
#852Hippo and dystrophin complex signaling in cardiomyocyte renewal
#853Nucleic acids related to MiR-29B-1-5P and uses thereof
#854ANTI-TUMOR THERAPY
#855Genetic correction of mutated genes
#856RNA interference agents for p21 gene modulation
#857MIR-520B SEQUENCE FOR INHIBITING CANCER GROWTH AND SPREAD AND MEDICINE THEREFOR
#858Compositions for treating muscular dystrophy
#859Antisense design
#860Methods Of Inhibiting Tumorigenesis In Colon Adenocarcinoma And Compositions Therefor
#861Cancer treatment and immune system regulation through FAT10 pathway inhibition
#862MODULATION OF APOLIPOPROTEIN C-III EXPRESSION
#863Methods of preserving and protecting pancreatic beta cells and treating or preventing diabetes by inhibiting NOX-1
#864COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#865Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#866Targeted elimination of bacterial genes
#867MUCOSAL HEALING PROMOTER
#868Post-selec modification methods
#869Antisense oligonucleotides (ODN) against Smad7 and uses thereof in medical field
#870NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI
#871Modulation of breast cancer growth by modulation of XBP1 activity
#872MicroRNA compounds and methods for modulating miR-122
#873Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (EMT) in cancer cells
#874Methods and compositions for treating insects
#875Methods of inhibiting cancer stem cells with HMGA1 inhibitors
#876Preventive or therapeutic agent for fibrosis
#877Composition including pint gene expression inhibitor or pint activity inhibitor and use thereof
#878Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer
#879Compositions and methods for decreasing tau expression
#880Method and kits for identifying of CDK9 inhibitors for the treatment of cancer
#881Recombinant AAV vectors useful for reducing immunity against transgene products
#882APTAMERS FOR TUMOR INITIATING CELLS
#883Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#884Reducing nonsense-mediated mRNA decay
#885Composition, kit, and method for diagnosing and treating ovarian cancer
#886Modified oligonucleotides for telomerase inhibition
#887Stem cell therapy in endometrial pathologies
#888Compositions and Methods for Inhibiting Expression of Factor V
#889Modulation of growth hormone receptor expression and insulin-like growth factor expression
#890Diagnosis and treatment of Friedreich's ataxia
#891siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#892Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling
#893Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy
#894Methods for Inhibiting Epithelial to Mesenchymal Transition by Inhibition of FOXS1
#895Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor
#896NUCLEIC ACID THAT INHIBITS EXPRESSION OF IRF5
#897MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER
#898METHODS AND COMPOSITIONS FOR PREVENTING ISCHEMIA REPERFUSION INJURY IN ORGANS
#899COMPOUNDS, COMPOSITION, METHODS, TARGETS FOR CANCER THERAPY
#900Oligonucleic acid variant libraries and synthesis thereof